ClinConnect ClinConnect Logo
Search / Trial NCT06741618

MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM

Launched by COLUMBIA UNIVERSITY · Dec 15, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Pr Ep Care Navigation

ClinConnect Summary

The MyPEEPS Mobile Plus trial is studying a new way to help young men who have sex with men (YMSM) prevent HIV infection. This program uses a mobile app to deliver important information and support about HIV prevention, especially focusing on a method called PrEP, which is a medication that helps keep HIV-negative people from getting HIV. Researchers want to see if using this app along with virtual support from peers can help more young men start using PrEP and reduce risky behaviors that could lead to HIV infection.

To be part of this trial, participants need to be between 17 and 25 years old, identify as male, non-binary, or genderqueer, and have had condomless sex with a male partner in the past year. They must also be HIV-negative and have access to a smartphone. Participants will receive guidance and support through the app, and the study aims to create a better understanding of how mobile technology can help prevent HIV in this high-risk group. If you're interested in joining, it's a chance to help improve HIV prevention strategies for young men like you.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • 17-25 years of age
  • identify as male, non-binary, or genderqueer
  • male sex assigned at birth
  • understand and read english
  • own a smartphone
  • report condomless anal sex with a male in the past year
  • HIV-negative (OraQuick verified)
  • Exclusion Criteria:
  • HIV Positive
  • If study staff determine participant unable to consent due to obvious and severe cognitive impairment or under the influence of drugs or alcohol
  • Transgender identity
  • currently report consistent use of PrEP

About Columbia University

Columbia University, a prestigious Ivy League institution located in New York City, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient care. With a robust network of research facilities and a commitment to innovation, Columbia University collaborates with a diverse range of healthcare professionals and researchers to explore groundbreaking therapies and treatment methodologies. The university's clinical trials encompass various fields, including oncology, neurology, and public health, aiming to translate scientific discoveries into effective clinical applications. Columbia University is dedicated to maintaining the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants while contributing to the global body of medical knowledge.

Locations

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Robert Garofalo, MD, MPH

Principal Investigator

Ann & Robert H Lurie Children's Hospital of Chicago

Lisa Kuhns, PhD, MPH

Principal Investigator

Ann & Robert H Lurie Children's Hospital of Chicago

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported